Unlimit Group A/S (CPH:UNLGRP)
0.0240
+0.0040 (20.00%)
At close: Apr 25, 2025
Unlimit Group Revenue
Unlimit Group had revenue of -5.28K DKK in the half year ending December 31, 2024, a decrease of -102.78%.
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
36.35M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | - | - | - |
Dec 31, 2023 | 20.00K | -891.63K | -97.81% |
Dec 31, 2022 | 911.63K | -630.71K | -40.89% |
Dec 31, 2021 | 1.54M | 1.50M | 3,297.08% |
Dec 31, 2020 | 45.40K | -8.73K | -16.12% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 290.40B |
DSV A/S | 167.11B |
Novonesis | 28.59B |
Danske Bank | 56.95B |
A.P. Møller - Mærsk | 399.66B |
Coloplast | 27.45B |
Carlsberg | 75.01B |
Ørsted | 71.03B |